These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 9360779

  • 1. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS, Wu Y, McMahon R, Yu L, Rossi JJ, Forman SJ.
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
    [Abstract] [Full Text] [Related]

  • 2. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K, Maruta A, Yoshida M, Yamazaki E, Motomura S, Kodama F, Matsuzaki M, Fujisawa S, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H.
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [Abstract] [Full Text] [Related]

  • 4. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB.
    Hematol Pathol; 1993 Jul; 7(2):91-106. PubMed ID: 8340287
    [Abstract] [Full Text] [Related]

  • 5. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R, Zentilin L, Fanin R, Giacca M.
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [Abstract] [Full Text] [Related]

  • 6. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
    Daubon T, Rochelle T, Bourmeyster N, Génot E.
    Eur J Cell Biol; 2012 Jan; 91(11-12):978-87. PubMed ID: 22717125
    [Abstract] [Full Text] [Related]

  • 7. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM, Kreisel FH, Zehnbauer BA, Kulkarni S, Hassan A, Frater JL.
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [Abstract] [Full Text] [Related]

  • 8. [The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].
    Yang X, Yang L, Gong YP, Chang H, Zhou RQ, Xing HY, Zheng BH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):793-6. PubMed ID: 21302443
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).
    Wu Y, Yu L, McMahon R, Rossi JJ, Forman SJ, Snyder DS.
    Hum Gene Ther; 1999 Nov 20; 10(17):2847-57. PubMed ID: 10584930
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX, Ripoche J, Pigeonnier V, Jazwiec B, Pigneux A, Moreau JF, Reiffers J.
    Exp Hematol; 1995 Dec 20; 23(14):1606-11. PubMed ID: 8542954
    [Abstract] [Full Text] [Related]

  • 11. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity.
    Shore SK, Nabissa PM, Reddy EP.
    Oncogene; 1993 Nov 20; 8(11):3183-8. PubMed ID: 8414522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA.
    J Exp Med; 1999 May 03; 189(9):1399-412. PubMed ID: 10224280
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
    Yi SJ, Lee HT, Groffen J, Heisterkamp N.
    Int J Mol Med; 2008 Oct 03; 22(4):453-8. PubMed ID: 18813851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.